Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Oct 2017 for Synact Pharma, €64k.
Filing timeline
BuySaleGhita Ovlesen and Jeppe Ovlesen, owner of Quantass Aps
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ghita Ovlesen and Jeppe Ovlesen, owner of Quantass Aps: trading record in brief
One trade, one date: on 6 October 2017, Ghita Ovlesen and Jeppe Ovlesen, owner of Quantass Aps disclosed an open-market purchase of €64k in Synact Pharma. No broader history exists yet. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Ghita Ovlesen and Jeppe Ovlesen, owner of Quantass Aps
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 9,071 shares@ SEK 67.9093100.0% of flowISIN SE0008241491FI:csv-d3a667c09f41538f7101Canonical exit: 1 Jan 2018 (T+90)
1 of 1 declaration